Cite

HARVARD Citation

    Sakai, F. et al. (2019). A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults. Headache. 59 (10), pp. 1731-1742. [Online]. 
  
Back to record